Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 15 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

40%

6 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed trials have results

Key Signals

1 recruiting

Enrollment reporting

Analytics

Phase 4
5(45.5%)
N/A
5(45.5%)
Phase 3
1(9.1%)
11Total
Phase 4(5)
N/A(5)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials
NCT06529237Active Not Recruiting

Malaria Molecular Surveillance in Mozambique (Phase 2)

Role: collaborator

NCT07038837Phase 4Recruiting

Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad

Role: collaborator

NCT07362498Completed

Health Systems Implementation and Molecular Surveillance of Multiple First-Line Treatments for Uncomplicated Malaria in Western Kenya

Role: collaborator

NCT05879224Not ApplicableCompleted

Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia

Role: collaborator

NCT06970600Not ApplicableCompleted

Efficacy of Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Under 12 Years at Four Sentinel Sites in Mozambique

Role: collaborator

NCT04245033Phase 4Completed

Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania

Role: collaborator

NCT05306067Completed

Plasmodium Falciparum Genomic Intelligence in Mozambique

Role: collaborator

NCT04301531Not ApplicableCompleted

Determining the Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence in Ghana

Role: collaborator

NCT05340153Phase 4Unknown

Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Cameroon

Role: collaborator

NCT04265573Completed

Feasibility, Acceptability and Costs of a Multiple First-lines Artemisinin-based Combination Therapies

Role: collaborator

NCT04829695Phase 4Unknown

Efficacy and Safety of Artesunate-amodiaquine and Artemether-lumefantrine for the Treatment of Malaria in Cameroon

Role: collaborator

NCT01967472Not ApplicableCompleted

Adherence to Antimalarial Drugs in Sierra Leone

Role: collaborator

NCT02536222Phase 4Completed

Accelerating the Reduction of Malaria Transmission in Kanel, Ranérou and Linguère Districts

Role: collaborator

NCT02517879Not ApplicableCompleted

Community Point Distribution of Insecticide Treated Bed Nets

Role: collaborator

NCT01456858Phase 3Completed

Insecticide Treated Polyethylene Sheeting for Prevention of Malaria in Emergencies

Role: collaborator

All 15 trials loaded